Research Antibodies Market Is Estimated To Witness High Growth Owing To The Increasing Demand For Antibodies In Drug Discovery And Development

Factors such as the increasing R activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.The Research Antibodies Market  is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793Market Segmentation:-On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016.

This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.Based on technology, the western blotting segment accounted for the largest share of the Research Reagents Market.

Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.Based on application, the proteomics segment accounted for the largest share of the Research Reagents Market.

The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R expenditure, and availability of funds from various organizations.Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the Research Antibodies and Reagents Market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.Key Market Opportunities: -             1 High Growth Opportunities in Emerging Markets             2 Increasing Demand for Personalized Medicine and Protein Therapeutics             3 Growths in Stem Cell and Neurobiology Research             4 Increasing Focus on Biomarker DiscoveryRegional Analysis:-North America accounted for the largest share of the Research Antibodies and Reagents Market in 2016, followed by Europe.

This regional segment shows significant market growth opportunities owing to the increasing research activities in the fields of proteomics and genomics, favorable government funding initiatives, and the growing focus of stakeholders on research projects.Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793Top Key Players:-The major players in the research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).

Global Research Antibodies Market size is expected to reach USD 4.30 billion by 2025.

Antibodies are secreted immunoglobin molecules mainly produced by plasma cells.

The market size is expected to expand at a CAGR of 6.1% in the upcoming period.In research antibodies, some technologies are used such as Immunohistochemistry, Western Blotting, Immunofluorescence, Immunoprecipitation, Flow Cytometry, ELISA, and others.

The “western blotting” segment held largest market share in 2016 and is expected to hold the highest market share in the upcoming period due to growing prevalence of diseases with limited treatment options such as HIV.

The segment is anticipated to grow at the highest CAGR during the forecast period owing to the increasing adoption of reagents containing primary research antibodies due to its related benefits such as greater specificity, easy availability and suitability to various research needs.Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/research-antibodies-market/request-sampleThe factors that play an important role in the growth of research antibodies market include increasing demand, growing population, increasing urbanization & industrialization, increasing funding for proteomics research & drug discovery, growing R activities & expenditure in the life science industry, increasing demand for personalized medicine & protein therapeutics, technological advancements and stringent government rules & regulations.

The market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others.

FEB 26, 2020: The global Research Antibodies market size is expected to reach USD 5.6 billion by 2027, exhibiting a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. Major market drivers include rise in R initiatives undertaken by biopharmaceutical and biotechnology companies and government bodies, growing interest in the study of neurobiology and stem cell, availability of technologically advanced products, and strategic collaborations among various market players and academic research organizations.Designer antibodies are also anticipated to attract the attention of various academic organizations for their use in the R of novel products.

For instance, in April 2019, scientists from ALS Canada Research Program developed a set of antibodies that can help in the detection of misfolded TDP-43 in various lab experiments that utilize post-mortem brain tissues.

According to the 2018-2019 Australian Budget, approximately USD 94 million was estimated for four years for new industry collaborations, research as well as new biomedical and medical programs.Additionally, rise in funds invested by pharmaceutical and biotechnology companies to enhance the study of proteomics and genomics is expected to drive the market.

For instance, in 2017, Biognosys Inc. raised USD 5 million in funds to increase, advance, and develop next-generation proteomics products and workflow for high throughput and high content protein analysis.

Rise in the number of major market players investing in advanced technologies and collaborating with other market players is also anticipated to positively impact market potential in the near future.

For instance, Abcellera uses technologically advanced techniques to test antibodies from single B cells, map and screen natural immune responses, and to discover novel antibody therapies.